Merline Saintil, a Director of Rocket Lab USA, Inc. (NASDAQ: RKLB), was granted 42,353 RSUs on June 12, 2024, pursuant to the Amended and Restated Non-Employee Director Compensation Policy. The RSUs vest in full on the earlier of the one-year anniversary of the grant date (June 12, 2025) or the next Annual Meeting of Stockholders, with no exercise price as they represent equity compensation at $0.00. Following the grant, Saintil owns 482,275 shares directly, reflecting an approximately 9.6% increase in her direct holdings. The filing, submitted on June 14, 2024, does not indicate a Rule 10b5-1 plan or any derivative activity in Table II. Such RSU grants are routine for independent directors and part of regular compensation practices, with no evidence of unusual patterns or timing relative to earnings (Rocket Lab's Q1 2024 earnings were reported May 7, 2024) or announcements.

This routine RSU grant signals standard board compensation practices rather than discretionary insider confidence in RKLB's prospects. Neutral overall, as it aligns with ongoing director pay without bullish purchase or bearish sale elements.